Europe risks falling behind in biomedical innovation as trials and capital shift abroad

A Politico EU opinion piece argues that Europe is losing ground in biomedical innovation, with clinical trials and investment moving to other regions, leaving patients without access to breakthrough treatments. The piece calls for policy intervention but provides no new data or specific events. The claim is an emerging narrative rather than a confirmed development.